Glucose homeostasis and insulin sensitivity in growth hormone-transgenic mice: A cross-sectional analysis

Biological Chemistry

Volumn 391, Issue 10, 2010, Pages 1149-1155

  Boparai, Ravneet K ^a   Arum, Oge ^a   Khardori, Romesh ^a   Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gluconeogenesis; glucose tolerance; growth hormone transgenic; insulin sensitivity

Indexed keywords

GROWTH HORMONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGING; ANIMALS; CATTLE; FEMALE; GLUCOSE; GROWTH HORMONE; HOMEOSTASIS; HUMANS; INSULIN; MALE; MICE; MICE, TRANSGENIC;

BOVINAE; MUS; MUS MUSCULUS;

EID: 78049387191     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.124     Document Type: Article

References (31)

1. Bartke, A. (2003). Can growth hormone (GH) accelerate aging? Evidence from GH transgenic mice. Neuroendocrinology 78, 210-216.
2. Bartke, A. (2008). Insulin and aging. Cell Cycle 7, 3338-3343.
3. Bartke, A., Chandrashekhar, V, Bailey, B., Zaczek, D., and Turyn, D. (2002). Consequences of growth hormone (GH) overexpres-sion and GH resistance. Neuropeptides 36, 201-208.
4. Bollano, E., Omerovic, E., Bohlooly-y, M., Kujacic, V., Madhu, B., Tornell, J., Isaakson, O., Soussi, B., Schulze, W., Fu, M.L., et al. (2000). Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology 141, 2229-2235.
5. Bouche, C., Serdy, S., Kahn, C.R., and Goldfine, A.B. (2004). The cellular fate of glucose and its endocrine relevance in type 2 diabetes. Endocr. Rev. 25, 807-830.
6. Clemmons, D.R. (2002). Role of insulin-like growth factor and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5, 181-183.
7. Colao, A., Baldelli, R., Marzullo, P., Ferretti, E., Ferone, D., Gar-giulo, P., Petretta, M., Tamburrano, G., Lombardi, G., and Liuzzi, A. (2000). Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of acromegalic cardiomyopathy. J. Clin. Endocrinol. Metab. 85, 193-199.
8. Davidson, M.B. (1987). Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev. 8, 115-131.
9. Doi, T., Striker, L.J., Quaife, C., Conti, F.G., Palmiter, R., Behringer, R., Brinster, R., and Striker, G.E. (1988). Progressive glomeru-losclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am. J. Pathol. 131, 398-403.
10. Dominici, F.P., Cifone, D., Bartke, A., and Turyn, D. (1999). Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone transgenic mice. J. Endocrinol. 161, 383-392.
11. Hansen, I., Tsalikian, E., Beaufrere, B., Gerich, J., Haymond, M., and Rizza, R. (1986). Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am. J. Physiol. 250, E269-E273.
12. Ibanez, L., Lopez-Bermejo, A., Diaz, M., Jaramillo, A., Marin, S., and de Zegher, F. (2010). Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin. J. Clin. Endocrinol. Metab. 95, 2234-2239.
13. Izzard, A.S., Emerson, M., Prehar, S., Leyses, N., Trainer, P., List, E.O., Kopchick, J.J., and Heagerty, M.M. (2009). The cardiovascular phenotype of a mouse model of acromegaly. Growth Horm. IGF Res. 19, 413-419.
14. Kopchick, J.J., Bellush, L.L., and Coschigano, K.T. (1999). Trans-genic models of growth hormone action. Annu. Rev. Nutr. 19, 437-461.
15. Leroi, A.M., Bartke, A., Benedictis, G.B., Franceschi, C., Gartner, A., Gonos, E., Feder, M.E., Kivisild, T., Lee, S., Kartal-Ozer, N., et al. (2005). What evidence is there for the existence of individual genes with antagonistic pleiotropy effects? Mech. Ageing Dev. 126, 421-429.
16. Lippe, B.M., Kaplan, S.A., Golden, M.P., Hendricks, S.A., and Scott, M.L. (1981). Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: response after acute and chronic human growth hormone administration. J. Clin. Endocrinol. Metab. 53, 507-513.
17. McCay, C.M., Crowell, M.F., and Maynard, L.A. (1935). The effect of retarded growth upon the length of lifespan and upon the ultimate body size. J. Nutr. 10, 63-79.
18. McGrane, M.M., de Vente, J., Yun, J.S., Bloom, J., Park, E.A., Wynshaw, A., Wagner, T.E., Rottman, F.M., and Hanson, R.W. (1988). Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 263, 11443-11451.
19. McGrane, M.M., Yun, J.S., Moorman, A.F.M., Lamers, W.H., Hen-drick, G.K., Arafah, B.M., Park, E.A., Wagner, T.E., and Hanson, R.W. (1990). Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 265, 22371-22379.
20. Menagh, P., Turner, R., Jump, D., Wong, C., Lowry, M., Yakar, S., Rosen, C., and Iwaniec, U.T. (2010). Growth hormone regulates the balance between bone formation and bone marrow adiposity. J. Bone Miner. Res. 25, 757-768.
21. Milton, S., Cecim, M., Li, Y.S., Wagner, T.E., and Bartke, A. (1992). Transgenic female mice with high human growth hormone levels are fertile and capable of lactation without having been pregnant. Endocrinology 131, 526-538.
22. Miquet, J.G., Gonzalez, M., Matos, M.N., Hansen, C.E., Louis, A., Bartke, A., Turyn, D., and Sotelo, A.I. (2008). Transgenic mice overexpressing GH exhibit hepatic upregulation of GH signaling mediators involved in cell proliferation. J. Endocrinol. 198, 317-330.
23. Moses, A.C., Young, S.C.J., Morrow, L.A., O'Brien, M., and Clemmons, D.R. (1996). Recombinant human insulin-like growth factor 1 increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 45, 95-100.
24. Nabarro, J.D.N. (1987). Acromegaly. Clin. Endocrinol. (Oxford) 26, 481-512.
25. O'Connell, T. and Clemmons, T.R. (2002). IGF-1/IGFBP-3 combination improves insulin resistance by GH dependent and independent mechanisms. J. Clin. Endocrinol. Metab. 87, 4356-4360.
26. Palmer, A.J., Chung, M.Y., List, E.O., Walker, J., Okada, S., Kop-chick, J.J., and Berryman, D.E. (2009). Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150, 1353-1360.
27. Pendergrass, W.R., Li, Y., Jiang, D., and Wolf, N.S. (1993). Decrease in cellular replicative potential in 'giant' mice trans-fected with the bovine growth hormone gene correlates to shortened lifespan. J. Cell. Physiol. 156, 96-103.
28. Rous, P. (1914). The influence of diet on transplanted and spontaneous tumors. J. Exp. Med. 20, 433-451.
29. Valera, A., Rodriguez-Gil, J.E., Yun, J.S., McGrane, M.M., Hanson, R.W., and Bosch, F. (1993). Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene. FASEB. J. 7, 791-800.
30. Wanke, R., Hermanns, W., Folger, S., Wolf, E., and Brem, G. (1991). Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview. Pediatr. Nephrol. 5, 513-521.
31. Wu, C., Okar, D.A., Kang, J., and Lange, A.J. (2005). Reduction of hepatic glucose production as a therapeutic target in the treatment of diabetes. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 51-59.